Biologics Services

Aurigene combines 25 years of expertise with cutting-edge facilities to guide your biologics projects from discovery through commercial manufacturing, meeting every unique requirement with precision.

Unlock the full potential of your biologics projects with Aurigene’s advanced services and industry-leading expertise, cultivated over 25 years. Our team comprises a global talent pool of highly skilled scientists who are dedicated to pushing the boundaries of biologics research. Working within state-of-the-art, cGMP-compliant facilities, we deliver a seamless, high-quality experience from discovery through to final commercial manufacturing, giving you confidence at every stage of your project.

At Aurigene, we provide end-to-end integrated development and manufacturing offerings in traditional and advanced drug modalities. Our mAb and protein therapeutics development is supported by in-house physiochemical and bio analytical development. We have a state-of-the-art cGMP viral vector manufacturing facility being commissioned. Our manufacturing services cater to both GMP and non-GMP manufacturing for preclinical development as well as GMP operations to support clinical or commercial needs for any recombinant protein expressed in suspension mammalian culture or E coli. We have technological flexibility in both stainless steel and single-use bioreactor systems, as well as ability to undertake alternating tangential flow for commercial scale manufacturing.

Speak to our experts

Our Biologics Services

Discovery Services :

Development and Manufacturing Services :

Why Aurigene Pharmaceutical Services?

20+

years’ experience

900+

scientists

125+

global clients

600+

projects

19

NCEs
commercialized

16

USFDA inspected
cGMP facilities

6

Biologics
commercialized

3

manufacturing countries
UK, Mexico, India

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

Page name

page url

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

I agree to receive updates from Aurigene

* I agree and accept the Privacy Policy and Terms of Use of this website.

Resources

JULY 02, 2026

The Journey from Scientific to patient impact

Home › Company › Aurigene 360°: The Journey from Scientific Insight to Patient Impact Publish on : January 25, 2026 Shares: Every medicine begins with a question. Sometimes with a scientist studying a protein structure late at night. Sometimes with a disease that still has no effective treatment. Sometimes with a ...

JUNE 12, 2026

The Journey from Scientific Insight to Patient Impact
Read More
FEBRUARY 25, 2025

Transforming Drug Discovery with Aurigene.AI
Read More
OCTOBER 01, 2024

PROTACs: Research for a life without cancer
Read More

View All

Advancement in personalized medicine and how the CRDMO industry is part of the solution

Personalized medicine is transforming the healthcare landscape by customizing treatment plans to individual patients’ unique genetic, clinical and environmental characteristics. These are effective and less invasive treatments for a wide range of conditions. Contract Research, Development and Manufacturing Organizations (CRDMOs) play an important role...

View All

Cell Line Development

We enable development of stable and high yielding recombinant Mammalian and Microbial lines. ...

View All

End-to-End Rebuild of a Complex Bicyclic Peptide Synthesis

...

View All

Identification of Degradants of Thermal and Oxidation Stress Studies of Empagliflozin and Linagliptin Tablets by HPLC-PDA and LC-MS Instrumental Techniques

2022

Objective of the manuscript is to identify the degradants observed in the thermal and oxidation degradation sample of Empagliflozin and Linagliptin tablets by using LC-MS and HPLC-PDA instrumental techniques. Thermal and oxidation degradation samples were injected in HPLC-PDA and LC-MS instruments. Mass of the degradants were detected by LC-MS technique, ...

Discovery of MAP855, an Efficacious and Selective MEK1/2 Inhibitor with an ATP-Competitive Mode of Action.

2005

Mutations in MEK1/2 have been described as a resistance mechanism to BRAF/MEK inhibitor treatment. We report the discovery of a novel ATP-competitive MEK1/2 inhibitor with efficacy in wildtype (WT) and mutant MEK12 models. Starting from a HTS hit, we obtained selective, cellularly active ...
Read More
Wang-OSO3H catalyzed green synthesis of bioactive isoindolo[2,1- a ]quinazoline-5,11–dione derivatives: An unexpected observation

2005

The sulphonic acid-functionalized Wang resin (Wang-OSO3H) was explored as a polymeric and recov- erable acidic catalyst for the synthesis of isoindolo[2,1- a ]quinazoline-5,11–dione derivatives under green conditions. Thus the Wang-OSO3H ...
Read More
Polycyclic Aromatic Compounds: A Simple and Efficient [(n-Bu3Sn)2MO4]n Catalyzed Synthesis of Quinazolinones and Dihydroquinazolinones

2005

A novel unprecedented approach for the synthesis of various quinazolinones and dihydroquinazolinones has been using [(n-Bu3Sn)2MO4]n as a catalyst. The reaction has been screened ...
Read More

View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

Proceed Back

Biologics Services